| 0 (0%) | 12-05 09:28 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.93 | 1-year : | 5.1 |
| Resists | First : | 4.22 | Second : | 4.36 |
| Pivot price | 4.18  |
|||
| Supports | First : | 3.99 | Second : | 3.32 |
| MAs | MA(5) : | 4.16  |
MA(20) : | 4.21 |
| MA(100) : | 3.67 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 52.5 |
D(3) : | 50.9 |
| RSI | RSI(14): 46.9 | |||
| 52-week | High : | 5.75 | Low : | 1.77 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ADVM ] has closed above bottom band by 41.9%. Bollinger Bands are 75.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 4.25 - 4.27 | 4.27 - 4.29 |
| Low: | 4.11 - 4.14 | 4.14 - 4.16 |
| Close: | 4.13 - 4.17 | 4.17 - 4.21 |
Fri, 05 Dec 2025
Will ADVM stock reach all time highs in 2025 - Weekly Volume Report & Growth Focused Investment Plans - Newser
Thu, 04 Dec 2025
Insider Selling: Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells 222,925 Shares of Stock - MarketBeat
Thu, 04 Dec 2025
Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells $1,260,000.00 in Stock - MarketBeat
Thu, 04 Dec 2025
Adverum Biotechnologies Releases Promising Phase 2 Trial Data - TipRanks
Thu, 04 Dec 2025
Adverum Biotechnologies, Inc. Announces Two-Year Data from LUNA Phase 2 Trial - TradingView
Thu, 04 Dec 2025
Is ADVM stock a dividend growth opportunity - 2025 Trading Recap & Low Risk High Win Rate Picks - Newser
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 22 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 12.3 (%) |
| Held by Institutions | 64 (%) |
| Shares Short | 811 (K) |
| Shares Short P.Month | 875 (K) |
| EPS | -8.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2.53 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -76.9 % |
| Return on Equity (ttm) | -417.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -3.5 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -8.44 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -138 (M) |
| Levered Free Cash Flow | -78 (M) |
| PE Ratio | -0.49 |
| PEG Ratio | 0 |
| Price to Book value | -1.65 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.67 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|